Merilog Injection, Solution
Product Images NDC 0024-5928

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Merilog (NDC 0024-5928). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Eee07a52 1102 4d48 9782 26061db175ad 01)

A line graph depicting serum glucose levels (mg/dL) over time (hours). Two lines represent different serum glucose trends within a 6-hour period, showing changes in glucose concentration measured at intervals from 0 to 6 hours.*

FDA Label Image

Figure 2 (Eee07a52 1102 4d48 9782 26061db175ad 02)

A line graph depicting free serum insulin concentration (mU/L) over time (hours), comparing two curves representing different insulin response profiles over a 6-hour period. The y-axis shows insulin concentration from 0 to 80 mU/L, while the x-axis spans 0 to 6 hours.*

FDA Label Image

Figure A (Eee07a52 1102 4d48 9782 26061db175ad 03)

An instructional black-and-white line drawing showing a close-up of two hands holding a small vial, one hand removing or placing the vial's cap. The vial likely represents a medication bottle, consistent with injectable drug preparation.*

FDA Label Image

Figure B (Eee07a52 1102 4d48 9782 26061db175ad 04)

An instructional illustration showing a hand peeling off a protective strip from the top of a vial, likely preparing the vial for injection or other medical use. The vial is held securely by the other hand at its base.*

FDA Label Image

Figure C (Eee07a52 1102 4d48 9782 26061db175ad 05)

Black and white instructional illustration showing a hand holding a syringe with the thumb pressing down on the plunger. An arrow points downward indicating the syringe plunger being pushed to expel liquid. This image likely demonstrates how to administer or prepare an injection.*

FDA Label Image

Figure D (Eee07a52 1102 4d48 9782 26061db175ad 06)

An instructional black and white line drawing showing two hands preparing an injection. One hand holds a syringe with a needle being inserted into or removed from a vial held by the other hand. A bold arrow indicates a twisting or pulling motion involving the syringe plunger or vial stopper.*

FDA Label Image

Figure E (Eee07a52 1102 4d48 9782 26061db175ad 07)

A black-and-white line drawing showing hands holding a vial and a syringe. One hand is holding an inverted vial, and the other hand is drawing liquid into a syringe from the vial. An arrow indicates the direction for pulling the syringe plunger.*

FDA Label Image

Figure F (Eee07a52 1102 4d48 9782 26061db175ad 08)

An instructional illustration showing two hands preparing an injection. One hand is holding a syringe with the plunger being pulled back, while the other hand supports the barrel. An arrow indicates the drawing up or pulling back motion of the syringe plunger.*

FDA Label Image

Figure G (Eee07a52 1102 4d48 9782 26061db175ad 09)

An anatomical illustration showing the recommended injection sites for MERILOG insulin aspart-szjj 100 IU/mL injection. The sites are marked in green on the upper arms, stomach, thighs, and buttocks of a human figure viewed from the front and back.*

FDA Label Image

Figure H (Eee07a52 1102 4d48 9782 26061db175ad 10)

An instructional line drawing showing a hand applying or removing a small adhesive patch or bandage from the inner forearm of the opposite arm, likely demonstrating a step in a medical or injection-related procedure.*

FDA Label Image

Figure I (Eee07a52 1102 4d48 9782 26061db175ad 11)

An instructional illustration showing a hand holding a syringe, with another hand pressing a plunger on the syringe, indicated by an arrow, demonstrating a step in administering an injection or expelling air from the syringe.*

FDA Label Image

Figure A (Eee07a52 1102 4d48 9782 26061db175ad 12)

Illustration showing recommended injection sites for the MERILOG insulin aspart-szjj injection solution. Highlighted areas on the front view include the upper arms, stomach, and thighs, while the rear view highlights the buttocks. These zones indicate where subcutaneous injections may be administered.*

FDA Label Image

Figure B (Eee07a52 1102 4d48 9782 26061db175ad 13)

An illustration of the MERILOG SoloStar insulin pen, showing labeled parts including the pen cap, rubber seal, cartridge holder with insulin scale, insulin name on the label, plunger, dose window with dose pointer, dose selector, and injection button. The image serves as a diagram of the pen's components relevant to dose selection and administration.*

FDA Label Image

Figure C (Eee07a52 1102 4d48 9782 26061db175ad 14)

MERILOG SoloStar prefilled pen injection containing insulin aspart-szjj at 100 IU/mL. The pen is designed for single patient use only, with a dosage form of injection solution intended for intravenous or subcutaneous administration. Manufactured by Sanofi-Aventis U.S. LLC. The label indicates a 3 mL volume in the pen.*

FDA Label Image

Figure D (Eee07a52 1102 4d48 9782 26061db175ad 15)

Illustration showing a person holding a MERILOG insulin aspart-szjj injection pen and removing the protective black pen cap by pulling it away from the pen body, indicating how to prepare the injection device.*

FDA Label Image

Figure E (Eee07a52 1102 4d48 9782 26061db175ad 16)

An illustration showing the dosage window of a Merilog SoloStar insulin aspart-szjj prefilled pen, highlighting the dose measurement increments visible through the pen's transparent section. The pen is labeled with its proprietary name, active ingredient, and indication for single patient use only.*

FDA Label Image

Figure F (Eee07a52 1102 4d48 9782 26061db175ad 17)

An instructional illustration showing two hands preparing an insulin pen for injection. One hand holds the pen, while the other uses a cloth or wipe to clean the pen's rubber stopper. The pen has visible measurement markings indicating dosage levels.*

FDA Label Image

Figure G (Eee07a52 1102 4d48 9782 26061db175ad 18)

An instructional illustration depicting two hands twisting off the plastic cap from a vial, demonstrating how to open an injection vial for use.*

FDA Label Image

Figure H (Eee07a52 1102 4d48 9782 26061db175ad 19)

An instructional illustration showing hands holding a MERILOG insulin aspart-szjj injection pen. The image depicts the removal of the pen cap by twisting it off with a blue arrow indicating the direction. A red circle with a line through it indicates not to pull the cap straight off.*

FDA Label Image

Figure I (Eee07a52 1102 4d48 9782 26061db175ad 20)

An instructional illustration showing how to connect the needle cap to a Merilog insulin aspart-szjj injection pen. It depicts one hand holding the pen and another hand holding the needle cap above a flat surface, demonstrating the process of attaching the cap for injection preparation.*

FDA Label Image

Figure J (Eee07a52 1102 4d48 9782 26061db175ad 21)

An instructional diagram showing a person removing the cap from a vial while holding a syringe with an orange label, depicting preparation for drawing medication from the vial. The image suggests aseptic technique for injection preparation, relevant to injectable drugs like MERILOG insulin aspart-szjj.*

FDA Label Image

Figure K (Eee07a52 1102 4d48 9782 26061db175ad 22)

An instructional illustration showing hands adjusting a dosing window on a MERILOG insulin aspart-szjj injection pen, highlighting the dose setting mechanism with a close-up of the dose indicator displaying numbers 1 and 2.*

FDA Label Image

Figure L (Eee07a52 1102 4d48 9782 26061db175ad 23)

Illustration showing a person holding an insulin injection pen with one hand and using the other hand to push the plunger, accompanied by an inset magnifying the needle tip where a small spray of liquid is emitted, demonstrating insulin delivery technique.*

FDA Label Image

Figure M (Eee07a52 1102 4d48 9782 26061db175ad 24)

MERILOG insulin aspart-szjj 100 units/mL injection in a 3 mL prefilled pen. The pen is orange and gray with a clear dosage window and black dials for setting injection dose. Labeled for single patient use only and indicated for subcutaneous and intravenous routes. Manufactured by Sanofi-Aventis U.S. LLC.*

FDA Label Image

Figure N (Eee07a52 1102 4d48 9782 26061db175ad 25)

An instructional illustration showing how to prepare a Merilog (insulin aspart-szjj) injection pen, specifically demonstrating the action of turning the dose knob on the pen. The pen is held by two hands, with an arrow indicating the direction to turn the dial.*

FDA Label Image

Figure O (Eee07a52 1102 4d48 9782 26061db175ad 26)

An illustration showing a close-up view of a numbered dose selector resembling that on an injection pen device. The visible numbers 18, 20, and 22 are displayed with the number 20 aligned in the center, suggesting dose adjustment functionality.*

FDA Label Image

Figure P (Eee07a52 1102 4d48 9782 26061db175ad 27)

An illustration showing a rotating dial or window with the numbers "20" and "22" prominently displayed, likely representing a date or year indicator on a device or packaging component.*

FDA Label Image

Figure Q (Eee07a52 1102 4d48 9782 26061db175ad 28)

An illustration showing a hand holding an insulin pen with a syringe attached. A blue arrow points to the left, indicating the direction to pull the syringe away from the pen, demonstrating removal or detachment.*

FDA Label Image

Figure R (Eee07a52 1102 4d48 9782 26061db175ad 29)

An instructional illustration showing how to hold and adjust the dose on a MERILOG (insulin aspart-szjj) injection pen. The image emphasizes twisting the brown dose selector knob with fingers, highlighting the correct and incorrect finger placement for adjusting the dose.*

FDA Label Image

Figure S (Eee07a52 1102 4d48 9782 26061db175ad 30)

An instructional illustration showing a hand holding an insulin syringe or pen, demonstrating the injection process. A close-up inset highlights the pen's dial set to a low dosage (0.1 units), accompanied by a clock indicating a 10-second wait time after injection. This diagram is relevant for administering MERILOG insulin aspart-szjj injection solution.*

FDA Label Image

Figure T (Eee07a52 1102 4d48 9782 26061db175ad 31)

An instructional illustration showing hands holding and preparing a MERILOG insulin aspart-szjj injection pen. The image depicts the removal of a protective cap from the needle, indicated by a blue arrow pointing to the right.*

FDA Label Image

Figure U (Eee07a52 1102 4d48 9782 26061db175ad 32)

An instructional illustration showing how to operate a Merilog (insulin aspart-szjj) injection pen. It depicts hands turning the dosing knob and pressing the injection button, with arrows indicating the directions for dose adjustment and injection activation.*

FDA Label Image

Figure V (Eee07a52 1102 4d48 9782 26061db175ad 33)

An instructional illustration showing a hand opening a container lid with one hand while the other hand holds a small component above the container, indicating the component is being inserted into the container. A blue curved arrow shows the direction of the insertion.*

FDA Label Image

Figure W (Eee07a52 1102 4d48 9782 26061db175ad 34)

An instructional illustration showing two hands preparing a MERILOG insulin aspart-szjj 100 [iU]/mL injection pen. The image depicts one hand holding the pen and the other hand removing or attaching the pen cap with an arrow indicating the direction of movement.*

FDA Label Image

Principal Display Panel (3 mL Pen Carton)

Merilog SoloStar (insulin aspart-szjj) injection 100 units/mL (U-100) prefilled pen label. The packaging is for five 3 mL prefilled pens intended for subcutaneous injection. The label specifies single patient use, no mixing with other insulins, and that needles are not included. Labeler is Sanofi-Aventis U.S. LLC.*

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Label for Merilog (insulin aspart-szjj) injection 100 units/mL (U-100) in a 10 mL multiple-dose vial. The label specifies subcutaneous injection only and includes manufacturer details: Sanofi-Aventis U.S. LLC. It also provides storage instructions, warnings, inactive ingredients, and states it is for Rx use only.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Merilog (insulin aspart-szjj) injection 100 units/mL (U-100) in a 10 mL multiple-dose vial. The label indicates subcutaneous injection use and refers to prescribing information for dosage details. Manufactured by Sanofi-Aventis U.S. LLC with NDC 0024-5927-00 and marked Rx only.*

FDA Label Image

Principal Display Panel (3 mL Pen Label)

Label for Merilog SoloStar injection featuring insulin aspart-szjj at a concentration of 100 units/mL (U-100). It is a 3 mL prefilled pen intended for single patient use only. The label indicates subcutaneous injection and directs to see prescribing information for dosage details. Manufactured by Sanofi-Aventis U.S. LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.